Skip to main navigation
Skip to search
Skip to main content
The Capital Region of Denmark's Research Portal Home
Dansk
English
Search content at The Capital Region of Denmark's Research Portal
Home
Hospitals/departments
Researchers
Research output
Activities
Prizes
Safety assessment of new antithrombotic agents: lessons from the EXTEND study on ximelagatran
EXTEND Study Group
Department of Orthopaedic Surgery
74
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Safety assessment of new antithrombotic agents: lessons from the EXTEND study on ximelagatran'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Alanine Aminotransferase
9%
Antithrombotic Agents
100%
Clinical Development
9%
Days of Treatment
9%
Enoxaparin
27%
Hip Fracture Surgery
9%
Hip Replacement
9%
Liver Enzymes
9%
Liver Injury
9%
Liver Toxicity
27%
Oral Direct Thrombin Inhibitor
9%
Postoperative Day
9%
Premature Termination
9%
Prolonged Administration
18%
Relative Efficacy
9%
Safety Assessment
100%
Study Termination
9%
Treatment Withdrawal
9%
Upper Normal Limit
9%
Venous Thromboembolism Prevention
9%
Ximelagatran
100%
Pharmacology, Toxicology and Pharmaceutical Science
Alanine Aminotransferase
9%
Anticoagulant Agent
100%
Enoxaparin
27%
Hepatotoxicity
27%
Hip Fracture
9%
Liver Enzyme
9%
Liver Injury
9%
Prematurity
9%
Safety Assessment
100%
Symptom
9%
Thrombin Inhibitor
9%
Venous Thromboembolism
9%
Ximelagatran
100%